Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan

Yasutaka Ueda^{1

2}, Naoshi Obara^{2

3}, Yuji Yonemura^{2

4}, Hideyoshi Noji^{2

5}, Masayoshi Masuko⁶, Yoshinobu Seki^{7

8}, Katsuya Wada⁹, Takahisa Matsuda¹⁰, Hirozumi Akiyama¹⁰, Takayuki Ikezoe^{2

5}, Shigeru Chiba^{2

11}, Yoshinobu Kanda^{2

12}, Tatsuya Kawaguchi^{2

13}, Tsutomu Shichishima^{2

5}, Hideki Nakakuma^{2

14}, Shinichiro Okamoto^{2

15}, Jun-Ichi Nishimura^{1

2}, Yuzuru Kanakura^{1

2}, Haruhiko Ninomiya^{16

17}

Affiliations

¹ Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
² Japan PNH Study Group, Tokyo, Japan.
³ Department of Hematology, University of Tsukuba, Tsukuba, Japan.
⁴ Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital, Kumamoto, Japan.
⁵ Department of Hematology, Fukushima Medical University, Fukushima, Japan.
⁶ Department of Stem Cell Transplantation, Niigata University Hospital, Niigata, Japan.
⁷ Department of Hematology, Niigata Prefectural Shibata Hospital, Shibata, Japan.
⁸ Department of Hematology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minami-Uonuma, Japan.
⁹ Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
¹⁰ Alexion Pharma G.K, Tokyo, Japan.
¹¹ Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
¹² Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
¹³ Departments of Hematology and Infectious Diseases, Kumamoto University, Kumamoto, Japan.
¹⁴ Kagoshima Tokusyukai Hospital, Kagoshima, Japan.
¹⁵ Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
¹⁶ Japan PNH Study Group, Tokyo, Japan. ninomiya.haruhiko.ft@u.tsukuba.ac.jp.
¹⁷ Department of Medical Sciences, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. ninomiya.haruhiko.ft@u.tsukuba.ac.jp.

PMID: 29980910
DOI: 10.1007/s12185-018-2486-3

Published Erratum

Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan

Yasutaka Ueda et al. Int J Hematol. 2018 Aug.

. 2018 Aug;108(2):233-235.

doi: 10.1007/s12185-018-2486-3.

Authors

Affiliations

¹ Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
² Japan PNH Study Group, Tokyo, Japan.
³ Department of Hematology, University of Tsukuba, Tsukuba, Japan.
⁴ Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital, Kumamoto, Japan.
⁵ Department of Hematology, Fukushima Medical University, Fukushima, Japan.
⁶ Department of Stem Cell Transplantation, Niigata University Hospital, Niigata, Japan.
⁷ Department of Hematology, Niigata Prefectural Shibata Hospital, Shibata, Japan.
⁸ Department of Hematology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minami-Uonuma, Japan.
⁹ Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
¹⁰ Alexion Pharma G.K, Tokyo, Japan.
¹¹ Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
¹² Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
¹³ Departments of Hematology and Infectious Diseases, Kumamoto University, Kumamoto, Japan.
¹⁴ Kagoshima Tokusyukai Hospital, Kagoshima, Japan.
¹⁵ Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
¹⁶ Japan PNH Study Group, Tokyo, Japan. ninomiya.haruhiko.ft@u.tsukuba.ac.jp.
¹⁷ Department of Medical Sciences, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. ninomiya.haruhiko.ft@u.tsukuba.ac.jp.

PMID: 29980910
DOI: 10.1007/s12185-018-2486-3

Abstract

In the original publication of this article, Tables 2, 3 and 4 were published incorrectly. The corrected tables 2, 3 and 4 are given in the following pages.

PubMed Disclaimer

Erratum for

Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.
Ueda Y, Obara N, Yonemura Y, Noji H, Masuko M, Seki Y, Wada K, Matsuda T, Akiyama H, Ikezoe T, Chiba S, Kanda Y, Kawaguchi T, Shichishima T, Nakakuma H, Okamoto S, Nishimura JI, Kanakura Y, Ninomiya H. Ueda Y, et al. Int J Hematol. 2018 Jun;107(6):656-665. doi: 10.1007/s12185-018-2409-3. Epub 2018 Jan 30. Int J Hematol. 2018. PMID: 29383624

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan

Affiliations

Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan

Authors

Affiliations

Abstract

Erratum for

Similar articles

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Abstract

Erratum for

Similar articles

Publication types

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources